Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Menu PhilippeChief Medical Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $72K 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,705 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 |  Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $118K 567 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Verma AbhimanyuChief Technology Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $5,016 1,030 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Valente ManuelaChief People Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,597 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Open-market sale · 10b5-1 plan | SELL | $237K 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 4,000 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 13 | Brown ShellyEVP, Chief Strategy Officer | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $97K 2,357 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 13 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $1,548 100 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 12 | Desmond SeanDirector, CEO & President |  NCNOnCino, Inc.Open-market sale · 10b5-1 plan | SELL | $263K 15.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 12 | Moat RossCHIEF OPERATING OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $115K 2,367 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 9 | Winkles IsabelleChief Financial Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $193K 8,274 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $515K 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 9 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $93K 30.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $273K 5,200 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 8 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $180K 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Gibson ChristopherDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $124K 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Feierstein Matthew DavidPresident |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $57K 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $198K 3,900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Brown ShellyEVP, Chief Strategy Officer | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $38K 900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $119K 10.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 4 | Allison JonathanChief Administrative Officer |  ROOTRoot, Inc.Open-market sale · 10b5-1 plan | SELL | $76K 1,706 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 4 | Prahm JeremyChief Investment Officer |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $93K 5,228 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $48K 900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 50 | Thompson Amanda JChief People Officer |  GAPGAP INCOpen-market sale | SELL | $583K 23.2K sh | Apr 7, 2026 traded Apr 6, 2026 |
| 43 | Bron OlivierCEO, Bloomingdale's |  MMacy's, Inc.Open-market sale | SELL | $130K 7,228 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 39 | Preston Tracy MEVP, CLO & Corporate Secretary | MMacy's, Inc. Open-market sale | SELL | $94K 5,271 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 36 | Thompson Amanda JChief People Officer | GAPGAP INC Open-market sale | SELL | $45K 1,788 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 35 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $60K 2,709 sh | Apr 7, 2026 traded Apr 7, 2026 |
| 34 | McClymont DonaldDirector, Chief Executive Officer |  INDIindie Semiconductor, Inc.Open-market sale | SELL | $55K 18.4K sh | Apr 7, 2026 traded Apr 6, 2026 |
| 33 | Leaver AndrewChief Executive Officer | ARQQArqit Quantum Inc. Open-market sale | SELL | $103K 7,595 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 32 | Griscom PaulSVP and Controller | MMacy's, Inc. Open-market sale | SELL | $13K 745 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $23K 1,030 sh | Apr 7, 2026 traded Apr 7, 2026 |
| 30 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $483K 17.5K sh | Apr 7, 2026 traded Oct 1, 2021 |